Evidence map›Paper›PMID 34067320›Full record

Observational studyNutrients2021

Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment.

Guillermo Bastida, Claudia Herrera-de Guise, Alicia Algaba, Yolanda Ber Nieto, Jose Manuel Soares, Virginia Robles, Fernando Bermejo, Esteban Sáez-González, Fernando Gomollón, Pilar Nos

Registry-linked trialAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07483645 (Effectiveness and Acceptability of a Liposomal Iron Supplement With Vitamin C and Fiber), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07483645 active not recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness and Acceptability of a Liposomal Iron Supplement With Vitamin C and Fiber (LISEFEX®): Observational, Descriptive, Prospective, Longitudinal, Multicenter Study in Mexican Subjects Diagnosed With Mild to Moderate Iron Deficiency Anemia.

TypeobservationalSponsorCarnot LaboratoriesRan2025 to 2026Enrolled74ConditionsIron Deficiency Anemia
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. SucrosomialPharmaceuticals (Basel, Switzerland) · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guillermo BastidaDepartment of Gastroenterology, CIBEREHD, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0001-7544-451X
Claudia Herrera-de GuiseCrohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain.
Alicia AlgabaDepartment of Gastroenterology, Instituto de Investigación Sanitaria Hospital La Paz (IdiPaz), Hospital Universitario de Fuenlabrada, 28046 Madrid, Spain.
Yolanda Ber NietoDepartment of Gastroenterology, Hospital Universitario San Jorge, 22004 Huesca, Spain.ORCID 0000-0002-5184-8349
Jose Manuel SoaresDepartment of Gastroenterology, Hospital Pedro Hispano, 4454-509 Matosinhos, Portugal.
Virginia RoblesCrohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, 08035 Barcelona, Spain.
Fernando BermejoDepartment of Gastroenterology, Instituto de Investigación Sanitaria Hospital La Paz (IdiPaz), Hospital Universitario de Fuenlabrada, 28046 Madrid, Spain.
Esteban Sáez-GonzálezDepartment of Gastroenterology, CIBEREHD, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0002-9042-2308
Fernando GomollónIBD Unit, Digestive Diseases Service, Instituto de Investigación Sanitaria de Aragón (IIS), CIBEREHD, Hospital Clínico Universitario "Lozano Blesa", 50009 Zaragoza, Spain.ORCID 0000-0003-0076-3529
Pilar NosDepartment of Gastroenterology, CIBEREHD, Hospital Universitari i Politècnic La Fe, 46026 Valencia, Spain.ORCID 0000-0002-6619-1511

Funding

ZAMBON S.A.U. financial support from ZAMBON S.A.U. for the writing of the manuscript
6 · The paper itself

Abstract

Iron deficiency anemia (IDA) is a common manifestation of Inflammatory Bowel Disease (IBD). Oral iron supplements are the treatment of choice, but are not always well tolerated. Sucrosomial

Indexed as

Quality of LifeAdministration, OralAdultAgedAged, 80 and overAnemia, Iron-DeficiencyDietary SupplementsFemaleFerric CompoundsHemoglobinsHumansInflammatory Bowel DiseasesIronMaleMiddle AgedProspective StudiesFerric CompoundsHemoglobinsIronsucrosomial ironTrace Elementsanemiainflammatory bowel diseaseiron deficiencyiron supplementationsucrosomial iron

Identifiers

PMID34067320
PMCPMC8224651

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.